BACKGROUND: The ubiquitin proteasome system maintains a dynamic equilibrium of proteins and prevents accumulation of damaged and misfolded proteins, yet its role in human cardiac dysfunction is not well understood. The present study evaluated ubiquitin proteasome system function in human heart failure and hypertrophic cardiomyopathy (HCM). METHODS AND RESULTS: Proteasome function was studied in human nonfailing donor hearts, explanted failing hearts, and myectomy samples from patients with HCM. Proteasome proteolytic activities were markedly reduced in failing and HCM hearts compared with nonfailing hearts (P<0.01). This activity was partially restored after mechanical unloading in failing hearts (P<0.01) and was significantly lower in HCM hearts with pathogenic sarcomere mutations than in those lacking these mutations (P<0.05). There were no changes in the protein content of ubiquitin proteasome system subunits (ie, 11S, 20S, and 19S) or in active-site labeling of the 20S proteolytic subunit beta-5 among groups to explain decreased ubiquitin proteasome system activity in HCM and failing hearts. Examination of protein oxidation revealed that total protein carbonyls, 4-hydroxynonenylated proteins, and oxidative modification to 19S ATPase subunit Rpt 5 were increased in failing compared with nonfailing hearts. CONCLUSIONS: Proteasome activity in HCM and failing human hearts is impaired in the absence of changes in proteasome protein content or availability of proteolytic active sites. These data provide strong evidence that posttranslational modifications to the proteasome may account for defective protein degradation in human cardiomyopathies.
BACKGROUND: The ubiquitin proteasome system maintains a dynamic equilibrium of proteins and prevents accumulation of damaged and misfolded proteins, yet its role in humancardiac dysfunction is not well understood. The present study evaluated ubiquitin proteasome system function in humanheart failure and hypertrophic cardiomyopathy (HCM). METHODS AND RESULTS: Proteasome function was studied in human nonfailing donor hearts, explanted failing hearts, and myectomy samples from patients with HCM. Proteasome proteolytic activities were markedly reduced in failing and HCM hearts compared with nonfailing hearts (P<0.01). This activity was partially restored after mechanical unloading in failing hearts (P<0.01) and was significantly lower in HCM hearts with pathogenic sarcomere mutations than in those lacking these mutations (P<0.05). There were no changes in the protein content of ubiquitin proteasome system subunits (ie, 11S, 20S, and 19S) or in active-site labeling of the 20S proteolytic subunit beta-5 among groups to explain decreased ubiquitin proteasome system activity in HCM and failing hearts. Examination of protein oxidation revealed that total protein carbonyls, 4-hydroxynonenylated proteins, and oxidative modification to 19S ATPase subunit Rpt 5 were increased in failing compared with nonfailing hearts. CONCLUSIONS: Proteasome activity in HCM and failing human hearts is impaired in the absence of changes in proteasome protein content or availability of proteolytic active sites. These data provide strong evidence that posttranslational modifications to the proteasome may account for defective protein degradation in humancardiomyopathies.
Authors: A L Bulteau; K C Lundberg; K M Humphries; H A Sadek; P A Szweda; B Friguet; L I Szweda Journal: J Biol Chem Date: 2001-05-25 Impact factor: 5.157
Authors: Stefan Hein; Eyal Arnon; Sawa Kostin; Markus Schönburg; Albrecht Elsässer; Victoria Polyakova; Erwin P Bauer; Wolf-Peter Klövekorn; Jutta Schaper Journal: Circulation Date: 2003-02-25 Impact factor: 29.690
Authors: Sawa Kostin; Lieven Pool; Albrecht Elsässer; Stefan Hein; Hannes C A Drexler; Eyal Arnon; Yukihiro Hayakawa; René Zimmermann; Erwin Bauer; Wolf-Peter Klövekorn; Jutta Schaper Journal: Circ Res Date: 2003-03-20 Impact factor: 17.367
Authors: Khuram W Chaudhary; Eric I Rossman; Valentino Piacentino; Agnes Kenessey; Chris Weber; John P Gaughan; Kaie Ojamaa; Irwin Klein; Donald M Bers; Steven R Houser; Kenneth B Margulies Journal: J Am Coll Cardiol Date: 2004-08-18 Impact factor: 24.094
Authors: Christos Kassiotis; Kalpana Ballal; Kari Wellnitz; Deborah Vela; Mei Gong; Rebecca Salazar; O Howard Frazier; Heinrich Taegtmeyer Journal: Circulation Date: 2009-09-15 Impact factor: 29.690
Authors: Atsushi Sanbe; Hanna Osinska; Jeffrey E Saffitz; Charles G Glabe; Rakez Kayed; Alina Maloyan; Jeffrey Robbins Journal: Proc Natl Acad Sci U S A Date: 2004-06-25 Impact factor: 11.205
Authors: Sarah B Scruggs; Nobel C Zong; Ding Wang; Enrico Stefani; Peipei Ping Journal: Am J Physiol Heart Circ Physiol Date: 2012-04-20 Impact factor: 4.733
Authors: Laurie K Svoboda; Khalilah G Reddie; Lian Zhang; Eileen D Vesely; Elizabeth S Williams; Sarah M Schumacher; Ryan P O'Connell; Robin Shaw; Sharlene M Day; Justus M Anumonwo; Kate S Carroll; Jeffrey R Martens Journal: Circ Res Date: 2012-07-27 Impact factor: 17.367